Global Health Perspectives in Dermatology

Global Health Perspectives in Dermatology

Global Health Perspectives in Dermatology

On this page

Global Health Perspectives in Dermatology - Skin Deep Worldwide

Global prevalence of neglected tropical skin diseases

  • Skin diseases affect > 900 million people globally, a major public health issue, especially in tropical, resource-limited settings (RLS).
  • High burden in RLS due to poverty, malnutrition, poor sanitation, and limited healthcare access.
  • Common tropical dermatoses:
    • Infections: Leprosy, Scabies, Cutaneous Leishmaniasis, Lymphatic Filariasis, Mycetoma, Yaws.
    • Non-infectious: Atopic dermatitis (modified by environment), Pellagra, Podoconiosis.
  • Impact:
    • Significant morbidity, disability (e.g., lymphedema).
    • Psychosocial consequences: stigma, social exclusion, reduced Quality of Life (QoL).
    • Economic strain on individuals and health systems.
  • Key Strategies:
    • Integrating skin health into Primary Healthcare (PHC).
    • Training community health workers.
    • Utilizing teledermatology for remote areas.
    • Mass Drug Administration (MDA) for endemic diseases.

⭐ India bears the highest burden of leprosy globally, accounting for over half of new cases. Early detection and Multi-Drug Therapy (MDT) are pivotal.

  • Challenges in RLS: 📌 MAPS - Manpower shortage, Access barriers, Poverty & hygiene, Stigma.

Global Health Perspectives in Dermatology - Tropical Skin Invaders

  • Leprosy (Hansen's Disease)
    • M. leprae. Anaesthetic hypopigmented patches, thickened peripheral nerves, nodules/plaques. TT↔LL spectrum.
    • Dx: Slit-skin smear (AFB), biopsy. Tx: MDT (Rifampicin, Dapsone, Clofazimine).

    ⭐ Paucibacillary MDT: 6 months; Multibacillary MDT: 12 months.

  • Cutaneous Leishmaniasis (CL)
    • Leishmania protozoa (sandfly vector). Chronic non-healing ulcers or crusted papules/nodules on exposed areas.
    • Dx: Smear/biopsy (LD bodies), PCR. Tx: Pentavalent antimonials (Na Stibogluconate), Amphotericin B.
  • Scabies
    • Sarcoptes scabiei mite. Intense nocturnal pruritus. Burrows, papules, vesicles (interdigital, wrists, axillae).
    • Tx: Permethrin 5% cream, oral Ivermectin. Treat contacts. Crusted (Norwegian) scabies in immunocompromised.
  • Lymphatic Filariasis (Elephantiasis)
    • Filarial worms (W. bancrofti, B. malayi; mosquito). Chronic lymphedema, hydrocele. Acute adenolymphangitis (ADL).
    • Dx: Night blood smear (microfilariae), antigen tests. Tx: Diethylcarbamazine (DEC), morbidity management.
  • Mycetoma (Madura Foot)
    • Fungi (eumycetoma) or Actinomycetes (actinomycetoma). Triad: painless swelling, draining sinuses, grains (color varies).
    • Dx: Grains microscopy/culture, imaging. Tx: Prolonged, agent-specific (antifungals/antibiotics), surgery.

Tropical dermatoses clinical presentations

Global Health Perspectives in Dermatology - Global Skin Shield

  • Global Burden: Skin diseases significantly impact Low- and Middle-Income Countries (LMICs), causing morbidity, disability, and stigma. Early, accessible care is vital.
  • WHO Initiatives: Focus on skin NTDs (e.g., Leprosy, Yaws, Scabies, LF) via Global NTD Roadmap 2021-2030. Aims to control, eliminate, or eradicate.
  • National Efforts (India):
    • National Leprosy Eradication Programme (NLEP): Strives for leprosy elimination (Grade 2 disability <1 case/million).
    • National Filaria Control Programme (NFCP): Targets Lymphatic Filariasis elimination through Mass Drug Administration (MDA).
  • Core Challenges:
    • Shortage of dermatologists, especially in rural areas; limited diagnostic tools.
    • Poor access to affordable medicines; pervasive social stigma delaying treatment.
  • Key Strategies:
    • Integrating dermatology into Primary Health Care (PHC).
    • Task-shifting to trained health workers.
    • Utilizing teledermatology for remote consultations.
    • Community engagement and health education to combat stigma.

⭐ > The WHO NTD Roadmap 2021-2030 targets 100% access to basic WASH services in areas endemic for skin NTDs.

Global Skin NTD Prevalence Map

High‑Yield Points - ⚡ Biggest Takeaways

  • Skin NTDs (Leprosy, Leishmaniasis, LF) are major global health burdens, requiring integrated control.
  • Leprosy: Cardinal signs for diagnosis; MDT prevents disability. WHO focus.
  • Leishmaniasis: Diverse skin lesions; vector control is vital. Endemic regions.
  • Lymphatic Filariasis: Causes lymphedema; MDA is key for elimination.
  • Scabies & deep fungal infections: Prevalent in tropics; demand community-based approaches.
  • Access to care: Critical challenge; teledermatology offers potential solutions.
  • Climate change: Impacts vector-borne skin diseases and UV-related conditions.

Practice Questions: Global Health Perspectives in Dermatology

Test your understanding with these related questions

A 42-year-old Bengali male presents with painless nodules over the face. The face is erythematous, and the surface of some of the large nodules is discolored. He gives a history of an insect bite in the past while he went to the jungle for work. What is the most likely diagnosis?

1 of 5

Flashcards: Global Health Perspectives in Dermatology

1/10

The most common type of leprosy in India is _____

TAP TO REVEAL ANSWER

The most common type of leprosy in India is _____

Borderline Tuberculoid (BT)

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial